West Yorkshire NHS patients will soon be trialling home testing for chronic kidney disease as part of its £30 million tech and AI innovation fund.The trial will use the Healthy.io early detection device, which…
Continue Reading
Qure.ai, a trailblazer in medical imaging solutions, celebrates its 13th FDA clearance with qXR-LN, an AI-powered tool for lung nodule detection. This pioneering technology signifies Qure.ai’s supremacy in AI-driven advancements for plain film radiography…
Continue Reading
Volpara Health Technologies (Volpara), a global leader in software for the early detection of breast cancer, is pleased to announce it has entered into an agreement to be acquired by Lunit Inc. Under the…
Continue Reading
Quibim, a trailblazer in Precision Medicine, has unveiled QP-Brain, an AI-driven software revolutionizing early-stage neurodegenerative disease identification. Acquiring regulatory clearance in the US, EU, and UK, this innovation signifies a pivotal advancement. QP-Brain’s precision…
Continue Reading
What You Should Know:
– Intelligent Scopes Corp, a subsidiary of Claritas HealthTech Ltd., and Mayo Clinic have joined forces to develop cutting-edge artificial intelligence (AI) solutions for bladder cancer diagnosis and treatment.
– The goal…
Continue Reading
What You Should Know:
– GE Healthcare (Nasdaq: GEHC) announced the US FDA 510K clearance of Critical Care Suite 2.1, featuring an innovative pneumothorax (PTX) detection algorithm that helps clinicians quickly and accurately identify and…
Continue Reading
Cytovale, a medical diagnostics company focused on developing technology that helps diagnose diseases, announced it scored $84 million in Series C funding led by Norwest Venture Partners with participation from other investors. WHAT THEY DO
Cytovale…
The RSNA Margulis Award-winning study introduces a game-changing AI-driven tool for pancreatic cancer detection on CT scans. Led by Po-Ting Chen, M.D., and the team, the research showcases the tool’s 90% sensitivity and 93%…
Continue Reading
Sepsis kills more than 11 million people worldwide each year and contributes to 20% of all global deaths. The disease is also a leading cause of death in U.S. hospitals, and a septic patient’s…
Continue Reading
What You Should Know:
Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced it has raised $84 million in Series C funding led by Norwest…
Continue Reading
